CRIS Current Research Information System

RICCI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.755
AS - Asia 17.775
EU - Europa 11.701
SA - Sud America 1.095
AF - Africa 1.058
Continente sconosciuto - Info sul continente non disponibili 918
OC - Oceania 26
Totale 51.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.276
VN - Vietnam 4.644
SG - Singapore 4.454
CN - Cina 4.349
IT - Italia 2.838
GB - Regno Unito 2.330
HK - Hong Kong 1.504
DE - Germania 1.463
SE - Svezia 1.255
FR - Francia 762
IN - India 753
BR - Brasile 742
RU - Federazione Russa 505
BD - Bangladesh 485
UA - Ucraina 472
IE - Irlanda 413
KR - Corea 371
NL - Olanda 344
JP - Giappone 327
CH - Svizzera 310
FI - Finlandia 294
CA - Canada 250
ZA - Sudafrica 228
CI - Costa d'Avorio 220
TG - Togo 204
EE - Estonia 178
SC - Seychelles 173
PH - Filippine 130
AT - Austria 128
AR - Argentina 124
NG - Nigeria 113
JO - Giordania 96
ID - Indonesia 91
TH - Thailandia 89
MX - Messico 86
BG - Bulgaria 76
TR - Turchia 70
PL - Polonia 68
IQ - Iraq 66
EC - Ecuador 65
CO - Colombia 50
ES - Italia 49
TW - Taiwan 48
BE - Belgio 47
IR - Iran 42
JM - Giamaica 42
PK - Pakistan 36
CL - Cile 33
MY - Malesia 32
SA - Arabia Saudita 30
GR - Grecia 28
LB - Libano 25
MA - Marocco 25
LT - Lituania 23
UZ - Uzbekistan 23
VE - Venezuela 23
AE - Emirati Arabi Uniti 22
AU - Australia 22
EG - Egitto 19
PY - Paraguay 18
PE - Perù 17
CR - Costa Rica 16
NP - Nepal 16
PT - Portogallo 15
UY - Uruguay 14
NI - Nicaragua 13
RO - Romania 13
TN - Tunisia 13
ET - Etiopia 12
HN - Honduras 12
KE - Kenya 12
RS - Serbia 12
DZ - Algeria 10
AL - Albania 9
GT - Guatemala 9
TT - Trinidad e Tobago 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
IL - Israele 8
KZ - Kazakistan 8
LA - Repubblica Popolare Democratica del Laos 8
HR - Croazia 7
OM - Oman 7
PR - Porto Rico 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
MU - Mauritius 6
NO - Norvegia 6
PA - Panama 6
SV - El Salvador 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LV - Lettonia 5
MD - Moldavia 5
SI - Slovenia 5
AM - Armenia 4
CY - Cipro 4
HU - Ungheria 4
AO - Angola 3
AZ - Azerbaigian 3
Totale 50.326
Salva come PNG Salva come JPEG
Città #
Singapore 3.078
Ashburn 2.026
Southend 1.982
Hong Kong 1.386
Fairfield 1.299
San Jose 1.201
Chandler 1.195
Ho Chi Minh City 1.118
Hanoi 922
Hefei 790
Santa Clara 716
Council Bluffs 580
Beijing 550
Dong Ket 505
Bologna 496
Princeton 495
Los Angeles 476
Wilmington 457
Houston 436
Woodbridge 423
New York 417
Seattle 416
Dublin 413
Dallas 373
Boardman 348
Cambridge 332
Seoul 316
Lauterbourg 312
Ann Arbor 308
Jacksonville 291
Bern 286
Tokyo 270
Helsinki 225
Milan 223
Abidjan 220
Lomé 204
Nanjing 187
Westminster 184
Da Nang 176
Padova 167
Berlin 146
Florence 146
Haiphong 145
Buffalo 140
Frankfurt am Main 137
Chicago 129
Rome 127
Redondo Beach 116
Munich 113
Shenyang 107
São Paulo 106
Guangzhou 105
Jinan 104
Abeokuta 101
Medford 101
Phoenix 100
Redmond 100
Shanghai 94
Amman 93
Vienna 86
Saint Petersburg 84
Atlanta 81
Changsha 81
Turin 81
Bremen 80
Tianjin 77
San Diego 75
Falkenstein 72
Nanchang 72
Bengaluru 71
Sofia 70
Johannesburg 69
Hebei 66
Nuremberg 62
Des Moines 61
Hangzhou 61
Dearborn 60
Toronto 60
Hải Dương 58
Mülheim 57
Orem 57
San Francisco 55
Biên Hòa 54
Redwood City 54
Zhengzhou 53
Montreal 52
Amsterdam 50
Brooklyn 50
Can Tho 47
The Dalles 46
Warsaw 45
London 44
Naples 43
Brussels 41
Pune 41
Lappeenranta 40
Jakarta 38
Tongling 38
Yubileyny 37
Norwalk 36
Totale 30.414
Salva come PNG Salva come JPEG
Nome #
Linfagioma cistico del surrene 391
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 380
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 374
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 339
Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study 335
Predictive factors for long-term survival in pancreatic ductal adenocarcinoma that underwent surgery: a systematic review and meta-analysis of literature 325
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 308
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 302
Pancreasectomia centrale o intermedia: indicazioni e note di tecnica 295
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 290
Comparison of Blumgart Anastomosis with Duct-to-Mucosa Anastomosis and Invagination Pancreaticojejunostomy After Pancreaticoduodenectomy: A Single-Center Propensity Score Matching Analysis 289
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 281
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 276
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 264
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 263
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 248
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 247
La chirurgia nell’adenocarcinoma gastrico resecabile: evidenze a confronto. 245
A critical and comprehensive systematic review and meta-analysis of studies comparing intracorporeal and extracorporeal anastomosis in laparoscopic right hemicolectomy 244
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre 242
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 242
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 242
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 241
Are the New IPMN’s Guideline Effective to Predict the Presence of Invasive IPM Carcinoma? A Single Center Experience. 240
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 235
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 234
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 233
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 228
Intraductal papillary mucinous neoplasms: the bologna experience. Lessons learned from 357 cases observed in a tertiary care center 228
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 227
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 225
Minimally Invasive Pancreaticoduodenectomy: What is the Best “Choice”? A Systematic Review and Network Meta-analysis of Non-randomized Comparative Studies 222
DRG chirurgici: rapporto costo/rimborso nella colecistectomia laparoscopica. 221
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 221
IL trattamento chirurgico dei tumori neuroendocrini pancreatico-duodenali nei pazienti con MEN 1. 220
Advanced laparoscopic surgery: comparison cost-reimbursement. 218
Il trattamento del moncone pancreatico dopo duodenocefalopancreasectomia: pancreatico-digiunostomia su ansa esclusa 217
A bizarre foreign body of the appendix: a case report. 217
Intraductal Papillary Mucinous Neoplasms: The Bologna Experience 217
Approccio mini-invasivo ai tumori benigni del fegato. 216
WHO 2010 classification of pancreatic endocrine tumors. Is the new always better than the old? 215
Clinical outcome of patients who underwent total pancreatectomy. 213
Impact of surgery and surveillance in the management of branch duct intraductal papillary mucinous neoplasms of the pancreas according to Fukuoka guidelines: the Bologna experience 213
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 211
Radical antegrade modular pancreatosplenectomy: Myth or reality? A systematic review and trial sequential meta-analysis 210
Multicolour versus monocolour inking specimens after pancreaticoduodenectomy for periampullary cancer: A single centre prospective randomised clinical trial 209
Carcinomi surrenalici: analisi di una casistica di 20 casi osservati presso la I Clinica Chirurgica dell’Università di Bologna. 207
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis 206
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 206
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 204
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 203
Pancreatic metastasis from renal cell carcinoma 202
Gli Strumenti dell’ EBM: Utilizzo del Nomogramma di Fagan in una diagnosi difficile 202
Co-morbidities and pancreatic stump treatment after pancreaticoduodenectomy: are they linked to postoperative morbidity? 200
Are the tumor size a limit to laparoscopic adrenalectomy? 200
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 200
Comparison of Efficacy and Safety of 4 Combinations of Laparoscopic and Intraoperative Techniques for Management of Gallstone Disease With Biliary Duct Calculi: A Systematic Review and Network Meta-analysis 200
Are There Prognostic Factors Related to Recurrence in Pancreatic Endocrine tumors? 199
Autoimmune Pancreatitis Associated with Anisakis Infection 198
Converted laparoscopic distal pancreatectomy: is there an impact on patient outcome and total cost? 197
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 197
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 197
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 195
Resezioni pancreatiche per cancro in pazienti anziani. 193
Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors 193
Laparoscopic appendectomy: Which factors are predictors of conversion? A high-volume prospective cohort study 193
The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours. 192
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 192
Groove Pancreatitis Associated with Pancreatic Adenocarcinoma and Autoimmune Pancreatitis. 191
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 190
First world consensus conference on pancreas transplantation: Part I—Methods and results of literature search 190
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 189
Searching for novel multimodal treatments in oligometastatic pancreatic cancer 187
”Intervento di prolassectomia per malattia emorroidaria: un’esperienza preliminare di una tecnica ormai molto diffusa” 185
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 185
State of the art biological therapies in pancreatic cancer 185
Benign pancreatic hyperenzymemia: Lights on a clinical challenge 185
La dimensione è un limite per l’approccio laparoscopico nella chirurgia del surrene? 184
Immunonutrition in patients who underwent major abdominal surgery: A comprehensive systematic review and component network metanalysis using GRADE and CINeMA approaches 183
Emorragia da proctite attinica: emostasi e trattamento. 183
Prospective validation of a preoperative risk score model based on pancreatic texture to predict postoperative pancreatic fistula after pancreaticoduodenectomy. 183
Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis – An international cohort study 182
Chirurgia pancreatica laparoscopica vs laparotomia: rapporto costi-benefici. Esperienza della I Clinica Chirurgica del S.Orsola-Malpighi. 181
Endoscopic treatment in very large rectal adenomas: Cold snare excision, strip biopsy e Nd-Yag Laser. 180
Efficacy and Cost-Effectiveness of Immediate Surgery versus a Wait-and-See Strategy for Sporadic Nonfunctioning T1 Pancreatic Endocrine Neoplasms. 180
Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets 180
Intraductal papillary mucinous neoplasms: the Bologna experience. Lessons learned from 357 cases observed in a tertiary care center 180
The Importance of Multiorgan Procurement in the Improvement of Residents’ Open Surgical Skills 179
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 179
Pancreatic cyst surveillance imposes low psychological burden 179
External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model 179
TRATTAMENTO CHIRURGICO DI UN PARAGANGLIOMA RETROPERITONEALE: A PROPOSITO DI UN CASO 178
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 177
Endoscopic Ultrasound-Guided Locoregional Treatments for Pancreatic Neuroendocrine Neoplasms 177
Chirurgia laparoscopica del fegato: esperienza iniziale e revisione della letteratura”. 177
Contrast-enhanced endoscopic ultrasound for the differential diagnosis between benign and malignant lymph nodes: a meta-analysis 177
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 176
Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature 175
Il percorso diagnostico-terapeutico dei tumori del pancreas nel Policlinico S.Orsola-Malpighi: risultati della chirurgia a 6 mesi dalla sua applicazione. 174
Tumori cistici del pancreas: casistica della I Clinica Chirurgica del S.Orsola-Malpighi. 174
Totale 21.933
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.004
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.451 0 0 190 390 374 213 73 380 210 289 1.560 772
2022/20235.574 478 809 270 647 410 449 169 296 934 179 488 445
2023/20241.828 152 267 137 157 142 398 143 131 40 106 84 71
2024/20257.053 287 922 643 423 992 404 496 277 124 531 429 1.525
2025/202619.815 1.641 1.741 1.560 1.303 1.837 952 2.816 829 3.716 1.649 919 852
2026/20272.939 479 1.042 1.418 0 0 0 0 0 0 0 0 0
Totale 51.328